ArticleCancers2024

Validation of the Scottish Inflammatory Prognostic Score (SIPS) in NSCLC Patients Treated with First-Line Pembrolizumab.

Igor Gomez-Randulfe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.